Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APHRODITE-1: Reducing Bruising in QWO Treatment for Cellulite
NCT05419505Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Jun 2022; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT05419505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419505.